Skip to main content

Part of the book series: Cancer Treatment and Research ((CTAR,volume 146))

Appendageal tumours (ATs) are neoplasms in which differentiation occurs toward one or more adnexal structures of the skin. The increased incidence, clinicopathologic spectrum and prognosis of keratinocyte skin cancers in organ transplant recipients (OTR) have all been well documented in recent years. In contrast, there are few publications relating to post-transplant ATs. Available reports provide evidence for a probable increased incidence of at least some of these neoplasms in OTRs. However, most published studies are essentially anecdotal observations or small case series, few data are available from systematic transplant cohort studies, and there is a dearth of reliable information on the prevalence of ATs in the general population. Such factors place major limitations on attempts to accurately assess relative risk of these tumours in OTRs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. LeBoit PE. Appendageal skin tumours: Introduction. In: World Health Organisation Classification of Tumours: Skin Tumours (Edited by LeBoit PE, Burg G, Weedon D, Sarasin A); IARC Press, Lyon, 2006. pp 123–4.

    Google Scholar 

  2. Alsaad KO, Obaidat NA, Ghazarian D. Skin adnexal neoplasms–part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol. 2007; 60:129–44.

    Article  PubMed  CAS  Google Scholar 

  3. Levi Z, Hazazi R, Kedar-Barnes I, Hodak E, Gal E, Mor E, Niv Y, Winkler J.. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Am J Transplant. 2007; 7(2):476–9.

    Article  PubMed  CAS  Google Scholar 

  4. Kazakov DV, Calonje E, Zelger B, Luzar B, Belousova IE, Mukensnabl P, Michal M. Sebaceous carcinoma arising in nevus sebaceus of Jadassohn: a clinicopathological study of five cases. Am J Dermatopathol. 2007; 29(3):242–8.

    Article  PubMed  Google Scholar 

  5. Liegl B, Leibl S, Okcu M, Beham-Schmid C, Regauer S. Malignant transformation within benign adnexal skin tumours. Histopathology. 2004; 45(2):162–70.

    Article  PubMed  CAS  Google Scholar 

  6. Kose R, Coban YK, Ciralik H. Eccrine porocarcinoma arising from preexisting eccrine poroma of the scalp after radiotherapy for cervical cancer. Dermatol Online J. 2006; 12(6):18.

    PubMed  Google Scholar 

  7. Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms–part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2007; 60:145–59.

    Article  PubMed  Google Scholar 

  8. Stone MS, Duncan WC, McGavran MH. Torre’s syndrome: exacerbation of cutaneous manifestations with immunosuppression. J Am Acad Dermatol. 1986; 15:1101–3.

    Article  PubMed  CAS  Google Scholar 

  9. Warschaw KE, Eble JN, Hood AF, Wolverton SE, Halling KC. The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies. J Cutan Pathol. 1997:24;511–518.

    Article  PubMed  CAS  Google Scholar 

  10. Dover JS, Ashur ML, Kwan TH. Sebaceous adenoma in a patient with acquired immunodeficiency syndrome. Arch Dermatol. 1988; 124:489–90.

    Article  PubMed  CAS  Google Scholar 

  11. Paraf F, Sasseville D, Watters AK, Naod S, Ginsburg O, Shibata H, Jothy S. Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome. Hum Pathol. 1995; 26:422–7.

    Article  PubMed  CAS  Google Scholar 

  12. Stockl FA, Dolmetsch AM, Codère F, Burnier MN. Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome. Can J Opthalmol. 1995; 30:324–6.

    CAS  Google Scholar 

  13. Yen MT, Tse DT. Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus. Opthal Plast Reconstr Surg. 2000; 16:206–10.

    Article  CAS  Google Scholar 

  14. Kuwahara RT, Rudolph TM, Skinner RB, Rasberry RD. A large ulcerated tumour on the back. Arch Dermatol. 2001; 137:1367–72.

    PubMed  CAS  Google Scholar 

  15. Mahlberg MJ, McGinnis KS, Draft KS, Fakharzadeh SS. Multiple eccrine poromas in the setting of total body irradiation and immunosuppression. J Am Acad Dermatol. 2006 Aug;55(2 Suppl):S46–9.

    Article  PubMed  Google Scholar 

  16. Blohme I, Larko O. Premalignant and malignant skin lesions in renal transplant patients. Transplantation. 1984; 37:165–167.

    Article  PubMed  CAS  Google Scholar 

  17. Oh JE, Ahn C, Yang JS, Min KW, Song KY, Kim SJ, Han JS, Kim S, Lee JS. Malignant proliferating trichilemmal tumour in renal transplantation. Nephrol Dial Transplant. 1997; 12(12):2768–71.

    Article  PubMed  CAS  Google Scholar 

  18. Happenreijs VPT, Reuser TTQ, Maay CM, De Keizer RJW, Maurits MP. Syringomatous carcinoma of the eyelid and orbit: a clinical and histopathological challenge. Br J Ophthamol. 1997; 81:668–72.

    Article  Google Scholar 

  19. Chastain MA, Millikan LE. Pilomatrix dysplasia in an immunosuppressed patient. J Am Acad Dermatol. 2000; 43:118–22.

    Article  PubMed  CAS  Google Scholar 

  20. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis. 2000; 36(1):167–76.

    Article  PubMed  CAS  Google Scholar 

  21. Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol. 2001; 44(6):932–9.

    Article  PubMed  CAS  Google Scholar 

  22. Snow S, Madjar DD, Hardy S, Bentz M, Lucarelli MJ, Bechard R, Aughenbaugh W, McFadden T, Sharata H, Dudley C, Landeck A. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001; 27(4):401–8.

    Article  PubMed  CAS  Google Scholar 

  23. Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere). Ann Oncol. 2001; 12:411–414.

    Article  PubMed  CAS  Google Scholar 

  24. Garrett AB, Scott KA. Trichilemmal carcinoma: a case report of a rare skin cancer occurring in a renal transplant patient. Transplantation. 2003; 76(7):1131.

    Article  PubMed  Google Scholar 

  25. Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation. 2004; 77(4):574–9. Review.

    Article  PubMed  CAS  Google Scholar 

  26. Mudhar HS, Parsons MA, Farr R, Ford A, Gudgeon P, Collins C, Chang BY. Steatosebocystadenoma: a novel cystic sebaceous neoplasm in an immunosuppressed individual. Histopathology. 2005; 47(4):429–3.

    Article  PubMed  CAS  Google Scholar 

  27. Harwood CA, McGregor JM, Swale VJ, Proby CM, Leigh IM, Newton R, Khorshid SM, Cerio R. High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol. 2003; 48(3):401–8.

    Article  PubMed  Google Scholar 

  28. Heaphy MR, Shamma HN, Hickmann M, White MJ. Cyclosporine-induced folliculodystrophy. J Am Acad Dermatol. 2004; 50:318–22.

    Article  Google Scholar 

  29. Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol; 2001; 116:246–53.

    Article  PubMed  CAS  Google Scholar 

  30. O’Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA, McGregor JM, Walker SL, Hanaoka F, Karran P. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005; 309(5742):1871–4.

    Article  PubMed  CAS  Google Scholar 

  31. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV induced p53 mutations in squamous-cell carcinoma. Proc Natl Acad Sci USA.1991;88:10124–8.

    Article  PubMed  CAS  Google Scholar 

  32. De Gruijl FR. Skin cancer and solar UV radiation. Eur J Cancer. 1999; 35:2003–9.

    Article  PubMed  Google Scholar 

  33. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis. 2005; 26:1657–87.

    Article  PubMed  CAS  Google Scholar 

  34. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutation Res. 2005; 571:185–205.

    PubMed  CAS  Google Scholar 

  35. Kruse R, Rutten A, Lamberti C, Hosseiny-Malayeri HR, Wang Y, Ruelfs C, Jungck M, Mathiak M, Ruzicka T, Hartschuh W, Bisceglia M, Friedl W, Propping P. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998; 63:63–70.

    Article  PubMed  CAS  Google Scholar 

  36. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van Den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000; 25(2):160–5.

    Article  PubMed  CAS  Google Scholar 

  37. Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, Lakhani SR. Loss of heterozygosity at cylindromatosis gene locus CYLD, in sporadic skin adnexal tumours. J Clin Pathol. 2001; 54:689–92.

    PubMed  CAS  Google Scholar 

  38. Harada H, Hashimoto KY, Ko MSH. The gene for multiple trichoepitheliomas maps to chromosome 9p21. J Invest Dermatol. 1996; 107:41–43.

    Article  PubMed  CAS  Google Scholar 

  39. Matt D, Xin H, Vortmeyer AO, Zhuang Z, Burg G, Boni R. Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol. 2000; 136:657–60.

    Article  PubMed  CAS  Google Scholar 

  40. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997; 16(1):64–7.

    Article  PubMed  CAS  Google Scholar 

  41. Sundberg JP, O’Banion MK, Shima A, Knupp C, Reichmann ME. Papillomas and carcinomas associated with a papillomavirus in European Harvest mice (Micromys minutus). Vet Pathol. 1988; 25:356–61.

    Article  PubMed  CAS  Google Scholar 

  42. Herber R, Liem A, Pitot H et al. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16E7 oncogene. J Virol. 1996; 70:1873–81.

    PubMed  CAS  Google Scholar 

  43. Hayashi N, Furihata M, Ohtsuki Y, Ueno H. Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Archiv. 1994; 424:503–9.

    Article  PubMed  CAS  Google Scholar 

  44. Rohwedder A, Keminer O, Hendricks C, Scaller J. Detection of HPV DNA in trichilemmomas by polymerase chain reaction. J Med Virol. 1997; 51:119–25.

    Article  PubMed  CAS  Google Scholar 

  45. Leonardi CL, Zhu WY, Kinsey WH, Penneys NS. Trichilemmomas are not associated with human papillomavirus DNA. J Cutan Pathol. 1991; 18(3):193–7.

    Article  PubMed  CAS  Google Scholar 

  46. Assadoullina A, Bialasiewicz AA, de Villiers EM, Richard G. Detection of HPV-20, HPV-23, and HPV-DL332 in a solitary eyelid syringoma. Am J Ophthalmol. 2000; 129:99–101.

    Article  PubMed  CAS  Google Scholar 

  47. Carlson JW, McGennen RC, Gomez R, Longbella C, Carter J, Carson LF. Sebaceous carcinoma of the vulva: a report and review of the literature. Gynecol Oncol. 1996; 60:489–91.

    Article  PubMed  CAS  Google Scholar 

  48. Escalonilla P, Grilli R, Canamero M, Soriano ML, Frina MC, Manzarbeitia F, Sainz R, Matsukura T, Requena L. Sebaceous carcinoma of the vulva. Am J Dermatopathol. 1999; 21:468–72.

    Article  PubMed  CAS  Google Scholar 

  49. Egawa K. Eccrine-centred distribution of human papillomavirus 63 infection in the epidermis of the plantar skin. Br J Dermatol. 2005; 152(5):993–6.

    Article  PubMed  CAS  Google Scholar 

  50. Hsu PJ, Liu CH, Huang CJ. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor. J Cutan Pathol. 2003; 30(3):206–10.

    Article  PubMed  Google Scholar 

  51. Requena L, Kutzner H, Hurt MA, Danta Cruz DJ, Mehregan DA, Mehregan DR, Mengesha YM, Kohler S, Argenyi ZB, McNiff J, Rudolph P, Sangueza OP. Malignant tumours with apocrine and eccrine differentiation. In: World Health Organisation Classification of Tumours: Skin Tumours (Edited by LeBoit PE, Burg G, Weedon D, Sarasin Al); IARC Press, Lyon, 2006. pp. 125–151.

    Google Scholar 

  52. Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol. 1996; 35(5 Pt 2):860–4.

    Article  PubMed  CAS  Google Scholar 

  53. McNiff J, McCalmont TH, Requena L, Sangueza OP, Vassalo C, Rosso R, Borroni G, Glusac EJ, Pichardo RO. Benign tumours with apocrine and eccrine differentiation. pp 139–148. In: World Health Organisation Classification of Tumours: Skin Tumours (Edited by LeBoit PE, Burg G, Weedon D, Sarasin A; IARC Press, Lyon, 2006).

    Google Scholar 

  54. de Berker DA, Taylor AE, Quinn AG, Simpson NB. Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes? J Am Acad Dermatol. 1996; 35(5 Pt 1):696–9.

    PubMed  Google Scholar 

  55. Mak R, Perrett C, Proby CM, Harwood CA. Sebaceous gland hyperplasia is common and therapeutically challenging in organ transplant recipients. Br J Dermatol. 2006; 155 (Suppl 1):36.

    Google Scholar 

  56. Moloney FJ, Keane S, O’Kelly P, Conlon PJ, Murphy GM. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol. 2005 Sep;153(3):574–8.

    Google Scholar 

  57. Salard D, Parriaux N, Derancourt C, Aubin F, Bresson-Hadni S, Miguet JP, Laurent R. Cutaneous complications following liver transplantation: epidemiologic and clinical study in 86 patients. Ann Dermatol Venereol. 2002; 129(10 Pt 1):1134–8.

    PubMed  CAS  Google Scholar 

  58. Salim A, Reece SM, Smith AG, Harrison D, Ramsay HM, Harden PN, Fryer AA. Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant. Am Acad Dermatol. 2006; 55(5):878–81.

    Article  Google Scholar 

  59. Perrett CM, McGregor J, Barlow RJ, Karran P, Proby C, Harwood CA. Topical photodynamic therapy with methyl aminolevulinate to treat sebaceous hyperplasia in an organ transplant recipient. Arch Dermatol. 2006; 142(6):781–2.

    Article  PubMed  Google Scholar 

  60. Walther T, Hohenleutner U, Landthaler M. Sebaceous gland hyperplasia as a side effect of cyclosporin A. Treatment with the CO2 laser. Dtsch Med Wochenschr. 1998; 123(25–26):798–800.

    Article  PubMed  CAS  Google Scholar 

  61. Pang SM, Chau YP. Cyclosporin-induced sebaceous hyperplasia in renal transplant patients. Ann Acad Med Singapore. 2005; 34(5):391–3.

    PubMed  CAS  Google Scholar 

  62. Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol. 2006; 54(2):290–300.

    Article  PubMed  Google Scholar 

  63. Torre D. Multiple sebaceous tumours. Arch Dermatol. 1968; 98:549–51.

    Article  PubMed  CAS  Google Scholar 

  64. Jiricny J. Replication errors: cha(lle)nging the genome. EMBO J. 1998; 22:6427–36.

    Article  Google Scholar 

  65. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58:5248–5257.

    PubMed  CAS  Google Scholar 

  66. Swann PF, Waters TR, Moulton DC, Xu Y-Z, Zheng Q, Edwards M, Mace R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science. 1996; 273:1109–11.

    Article  PubMed  CAS  Google Scholar 

  67. Karran P, Bignami M. DNA damage tolerance, mismatch repair and genome instability. BioEssays. 1994; 16:833–9.

    Article  PubMed  CAS  Google Scholar 

  68. Glaab WE, Risinger JI, Umar A, Barrett JC, Kunkel TA, Tindall KR. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus. Carcinogenesis. 1998; 19(11):1931–7.

    Article  PubMed  CAS  Google Scholar 

  69. Zouboulis CC, Boschnaknow A. Chronological ageing and photoageing in the human sebaceous gland. Clin Exp Dermatol. 2001; 26:600–7.

    Article  PubMed  CAS  Google Scholar 

  70. Perrett CM, Walker SL, O’Donovan P, Warwick J, Harwood CA, Karran P, McGregor JM Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol. 2008; 159(1):198–204.

    Article  PubMed  CAS  Google Scholar 

  71. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000; 143:614–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Harwood, C.A., Proby, C.M., Cerio, R. (2009). Appendageal Malignancies. In: Stockfleth, E., Ulrich, C. (eds) Skin Cancer after Organ Transplantation. Cancer Treatment and Research, vol 146. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78574-5_29

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-78574-5_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-78573-8

  • Online ISBN: 978-0-387-78574-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics